Prevalence and significance of white-coat hypertension and masked hypertension in type 2 diabetics

Hong Kong Medical Journal

Volumn 14, Issue 6, 2008, Pages 437-443

  Ng, C M ^a   Yiu, S F ^a   Choi, K L ^a   Choi, C H ^a   Ng, Y W ^a   Tiu, S C ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Albuminuria; Blood pressure monitoring, ambulatory; Diabetes mellitus, type 2; Hypertension

Indexed keywords

ALBUMIN;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MONITORING; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HONG KONG; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; URINARY EXCRETION; WHITE COAT HYPERTENSION; CROSS-SECTIONAL STUDY; HEART LEFT VENTRICLE FUNCTION; HYPERTENSION; MIDDLE AGED;

ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 60849107348     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-9.
2. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 2006;49:1761-9.
3. Instruction manual. Tracker non-invasive ambulatory blood pressure recorder. Issue 5. Reynolds Medical Part No. 8-60 130.
4. Quiñones MA, Douglas PS, Foster E, et al. ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on clinical competence. J Am Soc Echocardiogr 2003;16:379-402.
5. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005;45:142-61.
6. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272-98.
7. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-39.
8. Lurbe E, Torro I, Alvarez V, et al. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension 2005;45:493-8.
9. Kuriyama S, Otsuka Y, Iida R, Matsumoto K, Tokudome G, Hosoya T. Morning blood pressure predicts hypertensive organ damage in patients with renal diseases: effect of intensive antihypertensive therapy in patients with diabetic nephropathy. Intern Med 2005;44:1239-46.
10. Pickering TG. Effects of stress and behavioral interventions in hypertension: what is masked hypertension? J Clin Hypertens (Greenwich) 2003;5:171-4,176.
11. Leitão CB, Canani LH, Kramer CK, Boza JC, Pinotti AF, Gross JL. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care 2007;30:1255-60.
12. Eguchi K, Ishikawa J, Hoshide S, Pickering TG, Shimada K, Kario K. Masked hypertension in diabetes mellitus: a potential risk. J Clin Hypertens (Greenwich) 2007;9:601-7.
13. Benediktsson R, Padfield PL. Three simple steps for improving diagnostic accuracy in hypertension [in Icelandic]. Laeknabladid 2003;89:105-9.
14. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001;104:1385-92.
15. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999;131:564-72.
16. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006;47:846-53.
17. Nielsen FS, Gaede P, Vedel P, Pedersen O, Parving HH. White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy. Diabetes care 1997;20:859-63.
18. Puig JG, Ruilope LM, Ortega R. Antihypertensive treatment efficacy in type II diabetes mellitus. Dissociation between casual and 24-hour ambulatory blood pressure. Spanish Multicenter Study Group. Hypertension 1995;26:1093-9.
19. Burgess E, Mather K, Ross S, Josefsberg Z. Office hypertension in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991;34:684.
20. Glen SK, Elliott HL, Curzio JL, Lees KR, Reid JL. Whitecoat hypertension as a cause of cardiovascular dysfunction. Lancet 1996;348:654-7.
21. Gosse P, Promax H, Durandet P, Clementy J. 'White coat' hypertension. No harm for the heart. Hypertension 1993;22:766-70.
22. Strachan MW, Gough K, McKnight JA, Padfield PL. Ambulatory blood pressure monitoring: is it necessary for the routine assessment of hypertension in people with diabetes? Diabet Med 2002;19:787-9.
23. Beevers G, Lip GY, O'Brien E. ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques. BMJ 2001;322:981-5.
24. Zanchetti A, Bond MG, Hennig M, et al. Risk factors associated with alternations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998;16:949-61.
25. White WB. Ambulatory blood pressure as a predictor of target organ disease and outcome in the hypertensive patient. Blood Press Monit 1999;4:181-4.
26. Halligan AW, Shennan A, Lambert PC, Bell SC, Taylor DJ, de Swiet M. Automated blood pressure measurement as a predictor of proteinuric pre-eclampsia. Br J Obstet Gynaecol 1997;104:559-62.
27. Ramsay LE, Williams B, Johnston GD, et al. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ 1999;319:630-5.
28. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens 1996;9:1-11.
29. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) 2005;7:102-9.
30. O'Brien E, Asmar R, Beilin L, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005;23:697-701.
31. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007;30:479-88.
32. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006;354:2368-74.
33. Chavanu K, Merkel J, Quan AM. Role of ambulatory blood pressure monitoring in the management of hypertension. Am J Health Syst Pharm 2008;65:209-18.